The objective of this study was to compare MRI response assessment with metabolic O-(2-
18F-fluoroethyl)-l-tyrosine (18F-FET) PET response evaluation during antiangiogenic …

Establishing the diagnosis of a brain tumour is not always a straightforward process. Many
non-neoplastic neurological diseases can mimic brain neoplasms on neuroimaging or on …

Background The higher specificity of amino-acid positron emission tomography (AA-PET) in
the diagnosis of gliomas, as well as in the differentiation between recurrence and treatment …

The Response Assessment in Neuro-Oncology criteria were developed as an objective tool
for radiologic assessment of treatment response in high-grade gliomas. Imaging plays a …

Posttreatment high-grade gliomas are usually monitored with contrast-enhanced MRI, but its
diagnostic accuracy is limited as it cannot adequately distinguish between true tumor …

Cognitive function, with survival and response on brain imaging, is increasingly regarded as
an important outcome measure in patients with brain tumours. This measure provides us …

The management of patients with glioma usually requires multimodality treatment including
surgery, radiotherapy, and systemic therapy. Accurate neuroimaging plays a central role for …

Background MRI is one of the most important techniques to assess the treatment response
of gliomas. However, differentiating tumor recurrence (TuR) from treatment effects (TrE) …

Magnetic resonance imaging is integral to the care of patients with high-grade gliomas.
Anatomic detail can be acquired with conventional structural imaging, but newer …

Bevacizumab is thought to normalize tumor vasculature and restore the blood–brain barrier,
decreasing enhancement and peritumoral edema. Conventional measurements of tumor …